Abnormal fat distribution and use of protease inhibitors.
Wurtz
R
R
D000005:Abdomen / Q000473:pathology; D000273:Adipose Tissue / Q000473:pathology*; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D001823:Body Composition / Q000187:drug effects*; D005260:Female; D015658:HIV Infections / Q000503:physiopathology; D015497:HIV-1; D006801:Humans; D019469:Indinavir / Q000009:adverse effects*; D011020:Pneumonia, Pneumocystis / Q000503:physiopathology; D011480:Protease Inhibitors / Q000009:adverse effects*
D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D019469:Indinavir